Forward Regulatory Plan 2022-2024: Regulations Amending the Cosmetic Regulations

Title of Regulatory Initiative

Regulations Amending the Cosmetic Regulations

Enabling Act

Food and Drugs Act


Health Canada is proposing amendments to the Cosmetic Regulations to introduce a requirement to disclose certain fragrance allergens on the product label. In addition, Health Canada is proposing to amend the regulations to enhance regulatory oversight for cosmetics.

The amended regulations would inform consumers about the presence of certain fragrance allergens in the product, outside of the term "parfum". This would allow consumers to avoid products containing fragrance allergens to which they may be sensitive.

This initiative was identified as a commitment in the Minister of Health's 2021 Mandate Letter.

This regulatory initiative is a part of Health Canada's Regulatory Stock Review Plan.

Regulatory cooperation efforts (domestic and international)

This initiative is not part of a formal regulatory cooperation work plan.

The proposal would align Canada's requirements with those established by the European Commission. The disclosure of fragrance allergens on labels has been a requirement in the European Union since 2005.

Potential impacts on Canadians, including businesses

It is anticipated that the proposed amendments would increase consumer protection, specifically of vulnerable individuals who are sensitive to fragrance allergens, by requiring certain fragrance allergens to be disclosed on the label.

The cosmetic industry would be impacted by this proposal, as it would introduce label updates to many cosmetic products. To reduce the burden on industry, Health Canada will determine an appropriate coming-into-force strategy and other solutions, such as e-labelling options for small packaging.

Other proposed amendments are expected to improve the Department's risk assessments and support current enforcement practices. These are anticipated to have minimal impact on industry.


Canadians had an opportunity to provide comments on the proposed changes to the regulatory proposal through a notice to interested parties published on July 16, 2021, for a 45-day public comment period.

Canadians will have the opportunity to provide comments on the regulatory proposal during the Canada Gazette, Part I, public comment period, which is expected to take place spring 2022 and last 70 days.

Further information

Additional information can be requested from the departmental contact.

Departmental contact information

Geoff Barrett
Risk Management Bureau
Consumer and Hazardous Products Safety Directorate
Healthy Environments and Consumer Safety Branch
Health Canada

Telephone: 343-542-3045

Date the regulatory initiative was first included in the Forward Regulatory Plan

April 2021

Consult Health Canada's acts and regulations web page for:

Consult the following for links to the Cabinet Directive on Regulation and supporting policies and guidance, and for information on government-wide regulatory initiatives implemented by departments and agencies across the Government of Canada:

To learn about upcoming or ongoing consultations on proposed federal regulations, visit:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: